Geneva, March 20 -- International Clinical Trials Registry received information related to the study (TCTR20260227007) titled 'Effects of Spironolactone on Residual Kidney Function in Incremental Hemodialysis Patients: A Randomized Controlled Trial' on Feb. 27.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Bhumibol Adulyadej Hospital
Condition:
Incremental hemodialysis
Preserve residual kidney function (RKF)
Residual kidney function (RKF)
Incremental hemodialysis
Spironolactone
mineralocorticoid receptor antagonist
24-hour urine volume
Residual urea clearance (Kru)
Residual kidney function (RKF)
Incremental hemodialysis
Spironolactone
mineralocorticoid receptor antagonist
24-hour urine volume
Residual urea cl...